GlassScriptPhysician profile
Daniel J Sheehan
NPI 1619088671
$10,477.55
in general payments reported to CMS, 2019-2025
24 companies · $2,008 in 2025
The $2,008 reported for 2025 was more than what 76% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,483 · 2020: $1,283 · 2021: $740 · 2022: $1,274 · 2023: $1,742 · 2024: $1,945 · 2025: $2,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,317 · Education: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,317.37 |
| Education | $378.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,520.10 | 2019-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $1,209.12 | 2019-2025 | Tremfya, Simponi Aria, Remicade |
| Genzyme Corporation | $946.16 | 2019-2025 | |
| Abbvie INC. | $932.28 | 2019-2025 | Skyrizi |
| Ucb, INC. | $822.02 | 2021-2025 | Bimzelx, Cimzia |
| Amgen INC. | $770.95 | 2020-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $722.59 | 2019-2025 | |
| Lilly USA, LLC | $689.19 | 2019-2025 | Ebglyss, Taltz, Olumiant |
| Leo Pharma INC. | $684.24 | 2019-2025 | Adbry, Anzupgo |
| Pfizer INC. | $565.73 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $408.55 | 2019-2025 | Ilumya |
| Incyte Corporation | $267.08 | 2022-2025 | Opzelura |
| Galderma Laboratories, L.P. | $171.83 | 2020-2025 | Nemluvio |
| Almirall LLC | $122.76 | 2021-2023 | Seysara, Klisyri |
| Sanofi-Aventis U.S. LLC | $99.99 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $98.48 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $98.03 | 2019-2021 | |
| Prugen, INC. Pharmaceuticals | $84.46 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $74.11 | 2019 | |
| Arcutis Biotherapeutics, INC. | $68.91 | 2024-2025 | Zoryve |
| Genentech USA, INC. | $54.93 | 2019 | |
| Organon LLC | $30.77 | 2025 | Vtama |
| Encore Dermatology INC. | $20.76 | 2020 | |
| Epi Health, LLC | $14.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sheehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.